S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The “Perfect Storm” for Gold (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Top 5 AI Stocks to Buy for 2024 (Ad)
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
[Urgent!] Generational Wealth Gameplan (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The “Perfect Storm” for Gold (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Top 5 AI Stocks to Buy for 2024 (Ad)
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
[Urgent!] Generational Wealth Gameplan (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The “Perfect Storm” for Gold (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Top 5 AI Stocks to Buy for 2024 (Ad)
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
[Urgent!] Generational Wealth Gameplan (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
The “Perfect Storm” for Gold (Ad)
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Top 5 AI Stocks to Buy for 2024 (Ad)
Closing prices for crude oil, gold and other commodities
Abbott Laboratories Outlook is Healthy: Buy the Dip
[Urgent!] Generational Wealth Gameplan (Ad)
Prologis Stock Leading U.S. Logistics Boom
Johnson & Johnson’s Q1 Checkup: Mixed Results, Optimism Remains
Free Trial
NASDAQ:LENS

Presbia (LENS) Stock Price, News & Analysis

→ Did You Get Your Free Bitcoin Yet? (From Crypto Swap Profits) (Ad)
Free LENS Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.07
▼
$0.32
52-Week Range
N/A
Volume
N/A
Average Volume
122,366 shs
Market Capitalization
$258,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
LENS stock logo

About Presbia Stock (NASDAQ:LENS)

Presbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland.

LENS Stock News Headlines

February 7, 2024 | forbes.com
12 Of The Best Contact Lenses, According To An Ophthalmologist
February 1, 2024 | time.com
Contact Lens King Coupons
April 18, 2024 | Crypto 101 Media (Ad)
[Urgent!] Generational Wealth Gameplan
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
January 16, 2024 | bbc.co.uk
Real and virtual images
April 29, 2023 | forbes.com
If You Want To Wear Colored Contact Lenses, FDA Has A Warning
March 31, 2023 | cnet.com
Never Do These 13 Things With Contact Lenses
March 20, 2023 | bbc.co.uk
Types of lens
March 16, 2023 | bbc.co.uk
Convex and concave lenses
April 18, 2024 | Crypto 101 Media (Ad)
[Urgent!] Generational Wealth Gameplan
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
February 24, 2023 | dailymail.co.uk
I fell asleep with contact lenses in and a flesh-eating bug ate my EYE
February 17, 2023 | techcrunch.com
Snap introduces ray tracing technology for its AR lenses to enhance realism
January 6, 2023 | finance.yahoo.com
CCTV Lens Market valued at 1.5 Billion in 2022, is set to witness a growth of 8.93% in the next 7 years
October 15, 2022 | dailymail.co.uk
World's largest camera with a five-foot-wide lens powerful enough to spot a golf ball from 15 miles away is unveiled by astronomers - and will be used to capture the night sky ...
September 25, 2022 | thetimes.co.uk
Reusable contact lenses ‘raise risk of eye infection’
September 25, 2022 | nypost.com
Reusable contact lenses could cause blindness: study
May 4, 2022 | yahoo.com
Corneal Implants Market to hit USD 495 Million by 2028, Says Global Market Insights Inc.
November 13, 2021 | marketwatch.com
Presbyopia Correction Devices Market Report Leading Companies, Spotting Market Dynamics and Business Opportunities 2022 to 2027
See More Headlines
Receive LENS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Presbia and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/12/2016
Today
4/17/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:LENS
CUSIP
N/A
CIK
1591096
Web
www.presbia.com
Phone
(531) 551-1487
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-8,410,000.00
Net Margins
-36,604.35%
Pretax Margin
N/A
Return on Equity
-414.02%
Return on Assets
-195.56%

Debt

Debt-to-Equity Ratio
1.24
Current Ratio
2.88
Quick Ratio
2.82

Sales & Book Value

Annual Sales
$20,000.00
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.09 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
17,230,000
Free Float
N/A
Market Cap
$258,000.00
Optionable
Not Optionable
Beta
2.57
Elon Musk's Next Move Cover
Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Zohar Loshitzer
    Executive Chairman & Chief Executive Officer
  • Casey Lind
    Chief Operating Officer

Key Competitors

View All Competitors

LENS Stock Analysis - Frequently Asked Questions

How were Presbia's earnings last quarter?

Presbia PLC (NASDAQ:LENS) announced its quarterly earnings results on Friday, August, 12th. The medical instruments supplier reported ($0.32) earnings per share for the quarter, missing analysts' consensus estimates of ($0.25) by $0.07. The medical instruments supplier earned $0.01 million during the quarter, compared to analyst estimates of $0.04 million. Presbia had a negative net margin of 36,604.35% and a negative trailing twelve-month return on equity of 414.02%.

What other stocks do shareholders of Presbia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Presbia investors own include Ritter Pharmaceuticals (RTTR), AcelRx Pharmaceuticals (ACRX), Allena Pharmaceuticals (ALNA), Bellatrix Exploration (BXE), Second Sight Medical Products (EYES), Lilis Energy (LLEX), Marinus Pharmaceuticals (MRNS), Novavax (NVAX), Ampliphi Biosciences (APHB) and ArQule (ARQL).

When did Presbia IPO?

Presbia (LENS) raised $50 million in an IPO on Thursday, January 29th 2015. The company issued 4,200,000 shares at $11.00-$13.00 per share. Jefferies acted as the underwriter for the IPO.

This page (NASDAQ:LENS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
[Urgent!] Generational Wealth Gameplan
Crypto 101 Media
He Is Giving Away Bitcoin
Crypto Swap Profits
The “Perfect Storm” for Gold
Gold Safe Exchange
Urgent alert: open this for a huge profit potential
Timothy Sykes
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
Top 5 Tech Stocks to Buy for 2024
Daily Market Alerts
Biden out June 13; Kamala won’t replace him?
Paradigm Press
Your Money is Not Safe
American Alternative